Selected research
Market Analysis & Forecast
Global Autism Digital Therapy Market Analysis and Forecast 2026-2032
Market perspective
The global Autism Digital Therapy market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The North America market for Autism Digital Therapy is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
Europe market for Autism Digital Therapy is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
Read the full market overview
Asia-Pacific market for Autism Digital Therapy is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
The China market for Autism Digital Therapy is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
The major global companies of Autism Digital Therapy include Cognoa, IMUTISM, Impute, HARMAN, Roche, Autism 360, Brightline, EarliTec Diagnostics and SpectrumAi, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.
Report Includes
This report presents an overview of global market for Autism Digital Therapy, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.
This report researches the key producers of Autism Digital Therapy, also provides the revenue of main regions and countries. Of the upcoming market potential for Autism Digital Therapy, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Autism Digital Therapy revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Autism Digital Therapy market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for Autism Digital Therapy revenue, projected growth trends, production technology, application and end-user industry.
Autism Digital Therapy Segment by Company
Cognoa
IMUTISM
Impute
HARMAN
Roche
Autism 360
Brightline
EarliTec Diagnostics
SpectrumAi
Brain in Hand
Healios
Fumi Health Technology
Autism Digital Therapy Segment by Type
Prevention
Manage
Treat
Others
Autism Digital Therapy Segment by Application
Hospital
Rehabilitation Facility
Family
Others
Autism Digital Therapy Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.
2. To present the key players, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Autism Digital Therapy market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Autism Digital Therapy and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Autism Digital Therapy.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Revenue of Autism Digital Therapy in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 4: Detailed analysis of Autism Digital Therapy company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Autism Digital Therapy revenue, gross margin, and recent development, etc.
Chapter 8: North America by type, by application and by country, revenue for each segment.
Chapter 9: Europe by type, by application and by country, revenue for each segment.
Chapter 10: China type, by application, revenue for each segment.
Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.
Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.
Chapter 13: The main concluding insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Prevention
- Manage
- Treat
- Others
Applications
- Hospital
- Rehabilitation Facility
- Family
- Others
Companies covered
- Cognoa
- IMUTISM
- Impute
- HARMAN
- Roche
- Autism 360
- Brightline
- EarliTec Diagnostics
- SpectrumAi
- Brain in Hand
- Healios
- Fumi Health Technology
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Autism Digital Therapy Market by Type
- 1.2.1 Global Autism Digital Therapy Market Size by Type, 2021 VS 2025 VS 2032
- 1.2.2 Prevention
- 1.2.3 Manage
- 1.2.4 Treat
- 1.2.5 Others
- 1.3 Autism Digital Therapy Market by Application
- 1.3.1 Global Autism Digital Therapy Market Size by Application, 2021 VS 2025 VS 2032
- 1.3.2 Hospital
- 1.3.3 Rehabilitation Facility
- 1.3.4 Family
- 1.3.5 Others
- 1.4 Assumptions and Limitations
- 1.5 Study Goals and Objectives
2 Autism Digital Therapy Market Dynamics
- 2.1 Autism Digital Therapy Industry Trends
- 2.2 Autism Digital Therapy Industry Drivers
- 2.3 Autism Digital Therapy Industry Opportunities and Challenges
- 2.4 Autism Digital Therapy Industry Restraints
3 Global Growth Perspective
- 3.1 Global Autism Digital Therapy Market Perspective (2021-2032)
- 3.2 Global Autism Digital Therapy Growth Trends by Region
- 3.2.1 Global Autism Digital Therapy Market Size by Region: 2021 VS 2025 VS 2032
- 3.2.2 Global Autism Digital Therapy Market Size by Region (2021-2026)
- 3.2.3 Global Autism Digital Therapy Market Size by Region (2027-2032)
4 Competitive Landscape by Players
- 4.1 Global Autism Digital Therapy Revenue by Players
- 4.1.1 Global Autism Digital Therapy Revenue by Players (2021-2026)
- 4.1.2 Global Autism Digital Therapy Revenue Market Share by Players (2021-2026)
- 4.1.3 Global Autism Digital Therapy Players Revenue Share Top 10 and Top 5 in 2025
- 4.2 Global Autism Digital Therapy Key Players Ranking, 2024 VS 2025 VS 2026
- 4.3 Global Autism Digital Therapy Key Players Headquarters & Area Served
- 4.4 Global Autism Digital Therapy Players, Product Type & Application
- 4.5 Global Autism Digital Therapy Players Establishment Date
- 4.6 Market Competitive Analysis
- 4.6.1 Global Autism Digital Therapy Market CR5 and HHI
- 4.6.3 2025 Autism Digital Therapy Tier 1, Tier 2, and Tier 3
5 Autism Digital Therapy Market Size by Type
- 5.1 Global Autism Digital Therapy Revenue by Type (2021 VS 2025 VS 2032)
- 5.2 Global Autism Digital Therapy Revenue by Type (2021-2032)
- 5.3 Global Autism Digital Therapy Revenue Market Share by Type (2021-2032)
6 Autism Digital Therapy Market Size by Application
- 6.1 Global Autism Digital Therapy Revenue by Application (2021 VS 2025 VS 2032)
- 6.2 Global Autism Digital Therapy Revenue by Application (2021-2032)
- 6.3 Global Autism Digital Therapy Revenue Market Share by Application (2021-2032)
7 Company Profiles
- 7.1 Cognoa
- 7.1.1 Cognoa Company Information
- 7.1.2 Cognoa Business Overview
- 7.1.3 Cognoa Autism Digital Therapy Revenue and Gross Margin (2021-2026)
- 7.1.4 Cognoa Autism Digital Therapy Product Portfolio
- 7.1.5 Cognoa Recent Developments
- 7.2 IMUTISM
- 7.2.1 IMUTISM Company Information
- 7.2.2 IMUTISM Business Overview
- 7.2.3 IMUTISM Autism Digital Therapy Revenue and Gross Margin (2021-2026)
- 7.2.4 IMUTISM Autism Digital Therapy Product Portfolio
- 7.2.5 IMUTISM Recent Developments
- 7.3 Impute
- 7.3.1 Impute Company Information
- 7.3.2 Impute Business Overview
- 7.3.3 Impute Autism Digital Therapy Revenue and Gross Margin (2021-2026)
- 7.3.4 Impute Autism Digital Therapy Product Portfolio
- 7.3.5 Impute Recent Developments
- 7.4 HARMAN
- 7.4.1 HARMAN Company Information
- 7.4.2 HARMAN Business Overview
- 7.4.3 HARMAN Autism Digital Therapy Revenue and Gross Margin (2021-2026)
- 7.4.4 HARMAN Autism Digital Therapy Product Portfolio
- 7.4.5 HARMAN Recent Developments
- 7.5 Roche
- 7.5.1 Roche Company Information
- 7.5.2 Roche Business Overview
- 7.5.3 Roche Autism Digital Therapy Revenue and Gross Margin (2021-2026)
- 7.5.4 Roche Autism Digital Therapy Product Portfolio
- 7.5.5 Roche Recent Developments
- 7.6 Autism 360
- 7.6.1 Autism 360 Company Information
- 7.6.2 Autism 360 Business Overview
- 7.6.3 Autism 360 Autism Digital Therapy Revenue and Gross Margin (2021-2026)
- 7.6.4 Autism 360 Autism Digital Therapy Product Portfolio
- 7.6.5 Autism 360 Recent Developments
- 7.7 Brightline
- 7.7.1 Brightline Company Information
- 7.7.2 Brightline Business Overview
- 7.7.3 Brightline Autism Digital Therapy Revenue and Gross Margin (2021-2026)
- 7.7.4 Brightline Autism Digital Therapy Product Portfolio
- 7.7.5 Brightline Recent Developments
- 7.8 EarliTec Diagnostics
- 7.8.1 EarliTec Diagnostics Company Information
- 7.8.2 EarliTec Diagnostics Business Overview
- 7.8.3 EarliTec Diagnostics Autism Digital Therapy Revenue and Gross Margin (2021-2026)
- 7.8.4 EarliTec Diagnostics Autism Digital Therapy Product Portfolio
- 7.8.5 EarliTec Diagnostics Recent Developments
- 7.9 SpectrumAi
- 7.9.1 SpectrumAi Company Information
- 7.9.2 SpectrumAi Business Overview
- 7.9.3 SpectrumAi Autism Digital Therapy Revenue and Gross Margin (2021-2026)
- 7.9.4 SpectrumAi Autism Digital Therapy Product Portfolio
- 7.9.5 SpectrumAi Recent Developments
- 7.10 Brain in Hand
- 7.10.1 Brain in Hand Company Information
- 7.10.2 Brain in Hand Business Overview
- 7.10.3 Brain in Hand Autism Digital Therapy Revenue and Gross Margin (2021-2026)
- 7.10.4 Brain in Hand Autism Digital Therapy Product Portfolio
- 7.10.5 Brain in Hand Recent Developments
- 7.11 Healios
- 7.11.1 Healios Company Information
- 7.11.2 Healios Business Overview
- 7.11.3 Healios Autism Digital Therapy Revenue and Gross Margin (2021-2026)
- 7.11.4 Healios Autism Digital Therapy Product Portfolio
- 7.11.5 Healios Recent Developments
- 7.12 Fumi Health Technology
- 7.12.1 Fumi Health Technology Company Information
- 7.12.2 Fumi Health Technology Business Overview
- 7.12.3 Fumi Health Technology Autism Digital Therapy Revenue and Gross Margin (2021-2026)
- 7.12.4 Fumi Health Technology Autism Digital Therapy Product Portfolio
- 7.12.5 Fumi Health Technology Recent Developments
8 North America
- 8.1 North America Autism Digital Therapy Revenue (2021-2032)
- 8.2 North America Autism Digital Therapy Revenue by Type (2021-2032)
- 8.2.1 North America Autism Digital Therapy Revenue by Type (2021-2026)
- 8.2.2 North America Autism Digital Therapy Revenue by Type (2027-2032)
- 8.3 North America Autism Digital Therapy Revenue Share by Type (2021-2032)
- 8.4 North America Autism Digital Therapy Revenue by Application (2021-2032)
- 8.4.1 North America Autism Digital Therapy Revenue by Application (2021-2026)
- 8.4.2 North America Autism Digital Therapy Revenue by Application (2027-2032)
- 8.5 North America Autism Digital Therapy Revenue Share by Application (2021-2032)
- 8.6 North America Autism Digital Therapy Revenue by Country
- 8.6.1 North America Autism Digital Therapy Revenue by Country (2021 VS 2025 VS 2032)
- 8.6.2 North America Autism Digital Therapy Revenue by Country (2021-2026)
- 8.6.3 North America Autism Digital Therapy Revenue by Country (2027-2032)
- 8.6.4 United States
- 8.6.5 Canada
- 8.6.6 Mexico
9 Europe
- 9.1 Europe Autism Digital Therapy Revenue (2021-2032)
- 9.2 Europe Autism Digital Therapy Revenue by Type (2021-2032)
- 9.2.1 Europe Autism Digital Therapy Revenue by Type (2021-2026)
- 9.2.2 Europe Autism Digital Therapy Revenue by Type (2027-2032)
- 9.3 Europe Autism Digital Therapy Revenue Share by Type (2021-2032)
- 9.4 Europe Autism Digital Therapy Revenue by Application (2021-2032)
- 9.4.1 Europe Autism Digital Therapy Revenue by Application (2021-2026)
- 9.4.2 Europe Autism Digital Therapy Revenue by Application (2027-2032)
- 9.5 Europe Autism Digital Therapy Revenue Share by Application (2021-2032)
- 9.6 Europe Autism Digital Therapy Revenue by Country
- 9.6.1 Europe Autism Digital Therapy Revenue by Country (2021 VS 2025 VS 2032)
- 9.6.2 Europe Autism Digital Therapy Revenue by Country (2021-2026)
- 9.6.3 Europe Autism Digital Therapy Revenue by Country (2027-2032)
- 9.6.4 Germany
- 9.6.5 France
- 9.6.6 U.K.
- 9.6.7 Italy
- 9.6.8 Russia
- 9.6.9 Spain
- 9.6.10 Netherlands
- 9.6.11 Switzerland
- 9.6.12 Sweden
- 9.6.13 Poland
10 China
- 10.1 China Autism Digital Therapy Revenue (2021-2032)
- 10.2 China Autism Digital Therapy Revenue by Type (2021-2032)
- 10.2.1 China Autism Digital Therapy Revenue by Type (2021-2026)
- 10.2.2 China Autism Digital Therapy Revenue by Type (2027-2032)
- 10.3 China Autism Digital Therapy Revenue Share by Type (2021-2032)
- 10.4 China Autism Digital Therapy Revenue by Application (2021-2032)
- 10.4.1 China Autism Digital Therapy Revenue by Application (2021-2026)
- 10.4.2 China Autism Digital Therapy Revenue by Application (2027-2032)
- 10.5 China Autism Digital Therapy Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
- 11.1 Asia Autism Digital Therapy Revenue (2021-2032)
- 11.2 Asia Autism Digital Therapy Revenue by Type (2021-2032)
- 11.2.1 Asia Autism Digital Therapy Revenue by Type (2021-2026)
- 11.2.2 Asia Autism Digital Therapy Revenue by Type (2027-2032)
- 11.3 Asia Autism Digital Therapy Revenue Share by Type (2021-2032)
- 11.4 Asia Autism Digital Therapy Revenue by Application (2021-2032)
- 11.4.1 Asia Autism Digital Therapy Revenue by Application (2021-2026)
- 11.4.2 Asia Autism Digital Therapy Revenue by Application (2027-2032)
- 11.5 Asia Autism Digital Therapy Revenue Share by Application (2021-2032)
- 11.6 Asia Autism Digital Therapy Revenue by Country
- 11.6.1 Asia Autism Digital Therapy Revenue by Country (2021 VS 2025 VS 2032)
- 11.6.2 Asia Autism Digital Therapy Revenue by Country (2021-2026)
- 11.6.3 Asia Autism Digital Therapy Revenue by Country (2027-2032)
- 11.6.4 Japan
- 11.6.5 South Korea
- 11.6.6 India
- 11.6.7 Australia
- 11.6.8 Taiwan
- 11.6.9 Southeast Asia
12 South America, Middle East and Africa
- 12.1 SAMEA Autism Digital Therapy Revenue (2021-2032)
- 12.2 SAMEA Autism Digital Therapy Revenue by Type (2021-2032)
- 12.2.1 SAMEA Autism Digital Therapy Revenue by Type (2021-2026)
- 12.2.2 SAMEA Autism Digital Therapy Revenue by Type (2027-2032)
- 12.3 SAMEA Autism Digital Therapy Revenue Share by Type (2021-2032)
- 12.4 SAMEA Autism Digital Therapy Revenue by Application (2021-2032)
- 12.4.1 SAMEA Autism Digital Therapy Revenue by Application (2021-2026)
- 12.4.2 SAMEA Autism Digital Therapy Revenue by Application (2027-2032)
- 12.5 SAMEA Autism Digital Therapy Revenue Share by Application (2021-2032)
- 12.6 SAMEA Autism Digital Therapy Revenue by Country
- 12.6.1 SAMEA Autism Digital Therapy Revenue by Country (2021 VS 2025 VS 2032)
- 12.6.2 SAMEA Autism Digital Therapy Revenue by Country (2021-2026)
- 12.6.3 SAMEA Autism Digital Therapy Revenue by Country (2027-2032)
- 12.6.4 Brazil
- 12.6.5 Argentina
- 12.6.6 Chile
- 12.6.7 Colombia
- 12.6.8 Peru
- 12.6.9 Saudi Arabia
- 12.6.10 Israel
- 12.6.11 UAE
- 12.6.12 Turkey
- 12.6.13 Iran
- 12.6.14 Egypt
13 Concluding Insights
14 Appendix
- 14.1 Reasons for Doing This Study
- 14.2 Research Methodology
- 14.3 Research Process
- 14.4 Authors List of This Report
- 14.5 Data Source
- 14.5.1 Secondary Sources
- 14.5.2 Primary Sources
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst